“Outcome of 12-Weeks Triple Therapy (TT), Including Sofosbuvir (SOF), Ribavirin and Pegylated Interferon-Alfa in All Non-Cirrhotic Patients With Chronic Hepatitis-C Genotype-3 Infection”. Medical Forum Monthly, vol. 28, no. 7, May 2024, https://medicalforummonthly.com/index.php/mfm/article/view/4148.